OncoMed Pharmaceuticals, Inc.

Biological therapeutics targeting cancer stem cells

(2001)

Location:
Redwood City, CA

Management:
Paul Hastings, President & CEO

UM Inventor(s):
Michael F. Clarke, Max S. Wicha

Funding parties:
Adams Street Partners, Bay Partners, Delphi Ventures, De Novo Ventures, Genentech, GlaxoSmithKline, Latterell Venture Partners, Morgenthaler Ventures, Nomura Phase4 Ventures, US Venture Partners, The Vertical Group